OCDX
NASDAQOrtho Clinical Diagnostics Holdings plc
Latest news
25 items- SECSEC Form 15-12B filed by Ortho Clinical Diagnostics Holdings plc15-12B - Ortho Clinical Diagnostics Holdings plc (0001828443) (Filer)
- INSIDERSEC Form 4: Iskra Michael S. returned 150,000 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4 filed by Busky Joseph M4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Schlesinger Michael A. returned 87,637 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4 filed by Palaniappan Chockalingam4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Yates Robert Clifton returned 323,880 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Smith Christopher M returned 367,360 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Dilsaver Evelyn S returned 5,200 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Mac Mahon Thomas P returned 141,853 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Labrum Ronald K returned 109,985 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Hull Carl returned 62,183 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Perez David Brian returned 8,576 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Bechtel Karen returned 5,200 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Carlyle Group Inc. returned 118,106,000 units of Ordinary Shares to the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- SECOrtho Clinical Diagnostics Holdings plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Ortho Clinical Diagnostics Holdings plc (0001828443) (Filer)
- SECSEC Form 25-NSE filed by Ortho Clinical Diagnostics Holdings plc25-NSE - Ortho Clinical Diagnostics Holdings plc (0001828443) (Subject)
- SECOrtho Clinical Diagnostics Holdings plc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Ortho Clinical Diagnostics Holdings plc (0001828443) (Filer)
- PRQuidel and Ortho Announce Expected Closing of Ortho TransactionSAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Quidel Corporation (NASDAQ:QDEL) ("Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and Ortho Clinical Diagnostics Holdings plc ("Ortho"), one of the world's larger pure-play in vitro diagnostics companies, announced today that the closing of the previously announced Ortho transaction is expected to occur on May 27, 2022. On May 26, 2022, the High Court of Justice of England and Wales issued an order under Part 26 of the UK Companies Act sanctioning the scheme of arrangement to be undertaken by Ortho in connection with the business combinations (the "Ortho Scheme Order")
- PRQuidel and Ortho Announce Expected Closing of Ortho TransactionQuidel Corporation (NASDAQ:QDEL) ("Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and Ortho Clinical Diagnostics Holdings plc ("Ortho"), one of the world's larger pure-play in vitro diagnostics companies, announced today that the closing of the previously announced Ortho transaction is expected to occur on May 27, 2022. On May 26, 2022, the High Court of Justice of England and Wales issued an order under Part 26 of the UK Companies Act sanctioning the scheme of arrangement to be undertaken by Ortho in connection with the business combinations (the "Ortho Scheme Order"). The order will become effective once the Or
- SECOrtho Clinical Diagnostics Holdings plc filed SEC Form 8-K: Regulation FD Disclosure8-K - Ortho Clinical Diagnostics Holdings plc (0001828443) (Filer)
- SECOrtho Clinical Diagnostics Holdings plc filed SEC Form 8-K: Other Events, Submission of Matters to a Vote of Security Holders (Amendment)8-K/A - Ortho Clinical Diagnostics Holdings plc (0001828443) (Filer)
- SECOrtho Clinical Diagnostics Holdings plc filed SEC Form 8-K: Regulation FD Disclosure (Amendment)8-K/A - Ortho Clinical Diagnostics Holdings plc (0001828443) (Filer)
- SECOrtho Clinical Diagnostics Holdings plc filed SEC Form 8-K: Regulation FD Disclosure8-K - Ortho Clinical Diagnostics Holdings plc (0001828443) (Filer)
- PROrtho Clinical Diagnostics Shareholders Approve Quidel TransactionRARITAN, N.J., May 16, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) ("Ortho" or the "Company"), one of the world's largest pure-play in vitro diagnostics (IVD) companies, today announced that based on a preliminary vote count by its proxy solicitor, Ortho shareholders have voted to approve the combination of the Company with Quidel Corporation (NASDAQ:QDEL) ("Quidel") pursuant to the Business Combination Agreement, dated December 22, 2021, by and among the Company, Quidel, and the other parties thereto (the "BCA"). The closing of the transactions contemplated by the BCA is subject to sanction of the combination by the High Court of Justice of England and W
- SECSEC Form 425 filed by Ortho Clinical Diagnostics Holdings plc425 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Subject)
OCDX FAQ
7 questionsWhat does Ortho Clinical Diagnostics Holdings plc do?
Ortho Clinical Diagnostics Holdings plc engages in the vitro diagnostics business worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening...Where does OCDX stock trade?
Ortho Clinical Diagnostics Holdings plc (OCDX) is listed on NASDAQ.What sector and industry is OCDX in?
Ortho Clinical Diagnostics Holdings plc operates in the Health Care sector, Biotechnology: In Vitro & In Vivo Diagnostic Substances industry.When did Ortho Clinical Diagnostics Holdings plc go public?
Ortho Clinical Diagnostics Holdings plc (OCDX) completed its IPO in 2021.What are analysts saying about OCDX?
Ortho Clinical Diagnostics Holdings plc has had 8 recent analyst actions on file. The most recent action was from Evercore ISI Group: Outperform with a $2100.00 price target on 2022-02-17. Recent price targets range from $2100.00 to $3000.00.What companies are similar to OCDX?
Notable peers in the same industry include IDXX (IDEXX Laboratories Inc.), LNTH (Lantheus Holdings Inc.), ORKA (Oruka Therapeutics Inc.), NNNN (Anbio Biotechnology), CLDX (Celldex Therapeutics Inc.). Compare OCDX side-by-side with any of them on Quantisnow.How can I track OCDX on Quantisnow?
Quantisnow aggregates Ortho Clinical Diagnostics Holdings plc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow OCDX to receive live email and push alerts on every new disclosure.